Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Kobe J Med Sci ; 66(5): E166-E169, 2021 Mar 25.
Article in English | MEDLINE | ID: mdl-34001683

ABSTRACT

OBJECTIVE: Acute pulmonary edema associated with ritodrine hydrochloride is a rare, life-threatening complication, and dose and duration of ritodrine use are closely associated with this pathology. We report a case of acute pulmonary edema associated with short-duration infusion of ritodrine hydrochloride in a patient with pectus excavatum as an underlying factor. CASE REPORT: A 30-year-old healthy pregnant woman was treated with oral ritodrine for tocolysis between 31 and 35 weeks of pregnancy. At 36 weeks of gestation, she went into preterm labor, with premature rupture of the membrane and breech presentation, and received an infusion of ritodrine hydrochloride for a few hours. Although she was normotensive until labor onset, mild hypertension and proteinuria were recognized. Intraoperatively, a funnel-chest deformity was observed, and she developed postoperative pulmonary edema associated with dyspnea and wet cough and confirmed on chest radiography and arterial gas analysis, and recovered with supportive care. CONCLUSION: Small-dose infusion of ritodrine hydrochloride might cause pulmonary edema in patients with underlying medical problems, including pectus excavatum.


Subject(s)
Lung/drug effects , Obstetric Labor, Premature/prevention & control , Pulmonary Edema/chemically induced , Ritodrine/administration & dosage , Tocolytic Agents/administration & dosage , Uterine Contraction/drug effects , Adult , Cesarean Section , Female , Humans , Infusions, Parenteral , Pregnancy , Pulmonary Edema/drug therapy , Ritodrine/adverse effects , Ritodrine/therapeutic use , Tocolytic Agents/adverse effects , Tocolytic Agents/therapeutic use , Treatment Outcome
2.
Masui ; 56(5): 582-5, 2007 May.
Article in Japanese | MEDLINE | ID: mdl-17515100

ABSTRACT

Gastric cancer was detected in a 71-year-old man with severe aortic stenosis. According to ACC/AHA guidelines, aortic stenosis in the patient was so severe that noncardiac surgery was considered appropriate only after aortic valve replacement. However, due to uncontrollable hemorrhage from gastric cancer, total gastrectomy was urgently required. Surgery was performed under epidural and general anesthesia. Blood pressure and heart rate were stable during anesthetic induction, tracheal intubation and skin incision. Just after peritoneal incision, however, ST decreased significantly following hypertension and sinus tachycardia, which were controllable by deepening of the anesthetic level. This ST depression was dependent on heart rate but not blood pressure. Therefore, in order to control the heart rate and prevent myocardial ischemia, low dose landiolol was infused prophylactically. This agent regulated the heart rate below 85 beats per minute without inducing hypotension and prevented myocardial ischemia during the remaining anesthetic course including extubation and recovery from anesthesia. Although beta blocker is not generally recommended in patients with aortic stenosis, present case suggests that landiolol is effective and useful to prevent cardiac ischemia even in a patient with severe aortic stenosis.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Aortic Valve Stenosis/complications , Gastrectomy , Morpholines/therapeutic use , Myocardial Ischemia/prevention & control , Urea/analogs & derivatives , Aged , Humans , Male , Stomach Neoplasms/surgery , Urea/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...